15-Keto Prostaglandin E0 Dicyclohexylammonium Salt

CAS: 5094-14-4

Ref. TR-K202056

Informação sobre produto

• Nome: 15-Keto Prostaglandin E0 Dicyclohexylammonium Salt
• Sinónimos: (11a)-11-Hydroxy-9,15-dioxo-prostan-1-oic Acid Dicyclohexylammonium salt, 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid Dicyclohexylammonium salt, 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid Stereoisomer Dicyclohexylammonium salt, 11a-Hydroxy-9,15-diketoprostanoic Acid Dicyclohexylammonium salt, 11a-Hydroxy-9,15-dioxoprostanoic Acid Dicyclohexylammonium salt, 13,14-Dihydro-15-keto-PGE1 Dicyclohexylammonium salt, 13,14-Dihydro-15-ketoprostaglandin E1 Dicyclohexylammonium salt, 13,14-Dihydro-15-oxo-PGE1 Dicyclohexylammonium salt, 15-Oxodihydroprostaglandin E1 Dicyclohexylammonium salt, 15-keto-13,14-Dihydro-PGE1 Dicyclohexylammonium salt, 15-keto-13,14-Dihydroprostaglandin E1 Dicyclohexylammonium salt, Dihydro-15-ketoprostaglandin E1 Dicyclohexylammonium salt, U 21002 Dicyclohexylammonium salt, 13,14-Dihydro-15-keto-PGE1 Dicyclohexylammonium salt, (11α)-11-Hydroxy-9,15-dioxoprostan-1-oic acid, 11α-Hydroxy-9,15-diketoprostanoic acid, 11α-Hydroxy-9,15-dioxoprostanoic acid, 13,14-Dihydro-15-keto-PGE₁, 13,14-Dihydro-15-ketoprostaglandin E₁, 13,14-Dihydro-15-oxo-PGE₁, 15-Oxodihydroprostaglandin E₁, 15-keto-13,14-Dihydro-PGE₁, 15-keto-13,14-Dihydroprostaglandin E₁, Cyclopentaneheptanoic acid, 3-hydroxy-5-oxo-2-(3-oxooctyl)-, Cyclopentaneheptanoic acid, 3-hydroxy-5-oxo-2-(3-oxooctyl)-, stereoisomer, Dihydro-15-ketoprostaglandin E₁, Prostan-1-oic acid, 11-hydroxy-9,15-dioxo-, (11alpha)-, Prostan-1-oic acid, 11-hydroxy-9,15-dioxo-, (11α)-, U 21002

Descrição

Applications 15-Keto Prostaglandin E0 is a metabolite of Prostaglandin E1 (P838600) and has been shown to induce arterial thromboresistance in experimental animals and in man, but with several magnitudes higher concentrations than Prostaglandin E1. 15-Keto Prostaglandin E0 is also used as the active ingredient in compositions used for the treatment of external secretion disorders.
References Sinzinger, H., et al.: Prostag. Oth. Lipid M., 55, 265 (1998); Ueno, R. PCT Int. Appl. WO 2001005388 A2 20010125. Jan 25, 2001

• Marca: TRC

Propriedades químicas

• Peso molecular: 535.8
• Fórmula: C₂₀H₃₄O₅·C₁₂H₂₃N
• Cor/forma: Neat
• InChI: InChI=1S/C20H34O5.C12H23N/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h16-17,19,23H,2-14H2,1H3,(H,24,25);11-13H,1-10H2/t16-,17-,19-;/m1./s1
• Chave InChI: InChIKey=WFNXVCKMJNBQIU-KXPMFKKKSA-N
• SMILES: C1CCC(NC2CCCCC2)CC1.CCCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O